HMG

Also known as: Human Menopausal Gonadotropin

A fertility medication made from hormones extracted from postmenopausal women's urine. It contains both the hormones that stimulate egg development in women and sperm production in men. Used for fertility treatment in both sexes. Some bodybuilders also use it after steroid cycles to help their natural hormone production bounce back.

HMG (Human Menopausal Gonadotropin) is a fertility medication derived from the urine of postmenopausal women that contains both follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These are the two key gonadotropins — hormones produced by the pituitary gland that regulate reproductive function in both men and women. Brand names include Menopur, Pergonal, and Repronex.

In women, HMG is used as part of assisted reproduction protocols (IVF and IUI) to stimulate the ovaries to produce multiple mature follicles. The FSH component drives follicle growth while the LH component supports final maturation and estrogen production. In men, HMG stimulates the testes to produce both testosterone (via LH acting on Leydig cells) and sperm (via FSH acting on Sertoli cells). This dual stimulation makes HMG particularly valuable for treating male infertility caused by hypogonadotropic hypogonadism.

HMG has a half-life of approximately 24-30 hours (the LH component clears slightly faster than the FSH component). Standard fertility dosing is 75-150 IU intramuscularly or subcutaneously once daily, carefully monitored with ultrasound and blood work. In bodybuilding contexts, HMG is sometimes used during post-cycle therapy (PCT) at 75-150 IU every other day for 1-2 weeks to restore natural testosterone and sperm production after anabolic steroid use, often alongside HCG. The key benefit of HMG over HCG alone is the FSH component, which HCG does not provide — FSH is essential for restoring sperm production.

Dosage

75-150 IU intramuscular as directed by physician

Dosages shown are for research reference only. Always consult a qualified healthcare provider.

Half-Life

FSH component: 30 hours | LH component: 24 hours

Half-Life Calculator →

Shop Research-Grade Peptides

99%+ purity · US-based · third-party lab tested

Browse →

Getting Started — Here's What You'll Need

Effects

Fertility Treatment

FDA-approved for ovulation induction and spermatogenesis stimulation.

Ovulation Induction

Directly stimulates ovarian follicle development for fertility treatment.

Sperm Production

Stimulates both FSH and LH pathways to restore or enhance sperm production.

Mechanism of Action

Human Menopausal Gonadotropin is a purified urinary extract containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity, sourced from the urine of postmenopausal women. After menopause, the loss of ovarian negative feedback (estradiol and inhibin) results in dramatically elevated pituitary gonadotropin secretion — FSH and LH levels rise 10-20 fold, providing a natural source of these hormones for pharmaceutical extraction.

The FSH component binds to FSH receptors (FSHR) on Sertoli cells in males and granulosa cells in females. FSHR is a Gs-coupled GPCR that activates cAMP/PKA signaling, driving the expression of genes essential for gametogenesis. In males, FSH-stimulated Sertoli cells produce androgen-binding protein (which concentrates testosterone locally), inhibin B (which provides negative feedback to the pituitary), and multiple growth factors that support spermatogonial proliferation and differentiation through the stages of spermatogenesis. In females, FSH drives follicular development — stimulating granulosa cell proliferation, estradiol synthesis via aromatase induction, and the growth of ovarian follicles from the pre-antral to the pre-ovulatory stage.

The LH component acts on Leydig cells in males (stimulating testosterone production via the LHCGR/cAMP/StAR steroidogenic pathway) and on theca cells in females (stimulating androgen precursor production that granulosa cells convert to estradiol). In females undergoing fertility treatment, the LH component is also critical for final oocyte maturation and ovulation triggering. The combination of both FSH and LH activity in HMG provides more complete gonadal stimulation than either gonadotropin alone — FSH drives the cellular proliferation and maturation processes while LH provides the steroidogenic and final maturation signals. This dual activity is why HMG is sometimes preferred over purified FSH preparations in certain fertility protocols, particularly in hypogonadotropic patients who lack endogenous LH.

Regulatory Status

FDA approved for fertility (Menopur, Repronex). Prescription required. Available through fertility clinics and pharmacies.

Risks & Safety

Common

pain and bruising at the injection site, headache, bloating, tender breasts.

Serious

in women, can cause dangerous overstimulation of the ovaries (potentially life-threatening), and increases the chance of twins or higher-order multiples; in men, can cause breast tissue growth.

Rare

blood clots, twisted ovary, severe allergic reaction. Requires close monitoring with blood tests and ultrasounds during fertility treatment.

Compare HMG With

Research Papers

30
Regulation of ER-Resident Transcription Factor NFE2L1 in HEK293 Cells.

Published: February 8, 2026

AI Summary

NFE2L1 protein levels in cells depend on ER quality control pathways, with Hrd1 and the proteasome playing key roles. The work reveals how this transcription factor is regulated differently from related proteins, highlighting the variety of ways cells handle glycosylated proteins in the ER.

Pharmacologic Modulation of the PAR-2-ERK Axis by Statins Converts Inflammatory Survival Signalling into Apoptosis in Colorectal Cancer Cells.

Published: January 15, 2026

AI Summary

Statins turn off inflammatory survival signals in colorectal cancer cells and switch them back toward programmed cell death. Rosuvastatin showed stronger effects than atorvastatin at lower doses. These findings support the idea that statins may lower colorectal cancer risk and improve outcomes.

Intrinsically disordered regions in the yeast transcriptional regulator Ixr1 support prion-like behavior.

Published: January 4, 2026

AI Summary

The yeast regulator Ixr1 behaves like a prion in part because of its disordered regions, which can form amyloid aggregates. Its prion-like segments can substitute for those of another yeast prion protein. The protein's prion-like properties may be tempered by its interaction with Ssn8.

Comparative efficacy of r-hFSH Alfa + r-LH versus r-hFSH delta + hMG in poor ovarian responders.

Published: November 24, 2025

AI Summary

Two hormone regimens for poor ovarian responders—r-hFSH alfa plus r-LH versus r-hFSH delta plus hMG—were compared, filling a gap in head-to-head data for this challenging patient group. The results inform protocol selection when egg yield is limited.

Anti-diabetic effect of camel milk and protein hydrolysates in rat model.

Published: November 26, 2025

AI Summary

Enzymatically digested camel milk proteins boosted insulin release and beta-cell growth in diabetic rats, pointing to anti-diabetic effects. The work supports further study of camel milk hydrolysates as a potential dietary or therapeutic option for blood sugar control.

Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injury.

Published: November 25, 2025

AI Summary

Regulatory T cells in the gut use both IFN-gamma and IL-10 to help intestinal stem cells repair tissue after radiation or transplant injury. The combination of these signals promotes healing while preserving the stem cell pool, revealing a new role for inflammatory signals in repair.

An open-label study on ulotaront's effects on insulin-glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part I.

Published: January 21, 2026

AI Summary

Ulotaront, a TAAR1 agonist, was evaluated for its effects on blood sugar and insulin in schizophrenia patients with metabolic syndrome and prediabetes. The drug slows stomach emptying in this population, and the study examines how that influences glucose and insulin dynamics.

Investigation of Kai-Xin-San in alleviating cognitive impairment in aβ transgenic Caenorhabditis elegans through mitochondrial function regulation.

Published: December 9, 2025

AI Summary

Kai-Xin-San, a traditional Chinese formula, reduced paralysis and improved learning in worms with Alzheimer’s-like changes by supporting mitochondria and activating AMPK/SIRT1. The findings suggest a possible neuroprotective mechanism and support further study of the formula in cognitive decline.

Clinical Pregnancy Rate in Intrauterine Insemination and Associated Prognostic Factors.

Published: December 31, 2025

AI Summary

Factors that predict pregnancy success with intrauterine insemination were evaluated, as success rates remain modest at 7–13% per cycle. The findings help identify which patients and conditions are most likely to benefit from IUI.

Pro-inflammatory response of human iPSC-derived intestinal epithelial monolayers towards microbial toxins LPS and nigericin.

Published: February 7, 2026

AI Summary

Lab-grown intestinal cells from stem cells responded more strongly to bacterial toxins than standard Caco-2 cells, better mimicking gut inflammation. The iPSC model could improve screening of drugs and toxins that affect the intestinal barrier.

Deletion of C3G in hepatocytes impairs full liver maturation and alters glucose homeostasis.

Published: October 6, 2025

AI Summary

Removing C3G from liver cells in mice led to immature liver tissue, altered glucose handling, and stronger responses to glucagon. The results identify C3G as an important factor in liver maturation and metabolism.

Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes.

Published: August 28, 2025

AI Summary

Statins reduce inflammation through several pathways, including NF-kappaB and cytokine regulation, which may explain benefits beyond cholesterol lowering. The review discusses how these effects might be used in chronic inflammatory diseases and cancer, while noting safety concerns and ongoing debate.

Production and functional characteristics of a novel hirudin variant with better anticoagulant activities than bivalirudin.

Published: December 6, 2025

AI Summary

A new recombinant hirudin variant, HMg, showed stronger anticoagulant activity than bivalirudin in lab tests and could be produced at scale in bacteria. The work suggests a path toward more affordable blood-thinning drugs for cardiovascular disease.

Association between meeting the 24-hour movement guidelines and cardiometabolic risk factors in toddlers, preschoolers, children, and adolescents: A systematic review and meta-analysis.

Published: November 13, 2025

AI Summary

Fewer than 9% of children and teens met all parts of the 24-hour movement guidelines, but those who did had lower odds of obesity, better blood lipids, and healthier blood pressure and glucose. Meeting all three—physical activity, limited screen time, and adequate sleep—together mattered more than any single component alone.

Outcomes After Switching to Faricimab in Neovascular Age-Related Macular Degeneration: Data From the Fight Retinal Blindness! Registry.

Published: December 26, 2025

AI Summary

One-year outcomes were described for eyes switched from older anti-VEGF drugs to faricimab for wet macular degeneration in routine practice. The data help clinicians understand real-world results when changing to this newer treatment.

Liraglutide Attenuates Atorvastatin-Induced Hepatotoxicity by Restoring GLP-1R Expression and Activating Nrf2 and Autophagy Pathways in Wistar Rats.

Published: July 15, 2025

AI Summary

Liraglutide reduced liver damage caused by atorvastatin in rats by boosting antioxidant defenses, dampening inflammation, and promoting autophagy. The findings suggest GLP-1 agonists might help protect against statin-related liver injury, though human studies are needed.

Glucose restriction shapes pre-metastatic innate immune landscapes in the lung through exosomal TRAIL.

Published: October 1, 2025

AI Summary

Restricting glucose slowed primary tumor growth but unexpectedly increased lung metastasis by depleting natural killer cells via exosomal TRAIL. Blocking TIGIT reversed this effect and improved anti-tumor outcomes, revealing both risks and opportunities when targeting cancer metabolism.

Simvastatin inhibits the immunosuppressive effects of endometrial cancer-associated mesenchymal stem cells through TGF-β2/SMAD2/3 signaling and reduces tumor growth.

Published: June 30, 2025

AI Summary

Simvastatin reversed the immunosuppressive effects of endometrial cancer–associated stem cells on T and NK cells, partly by blocking TGF-beta2 signaling. Combined with NK cell therapy, it slowed tumor growth in mice, suggesting a possible repurposing of statins for endometrial cancer treatment.

Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis.

Published: June 30, 2025

AI Summary

A network meta-analysis compared different ovarian stimulation protocols used in fertility treatment. The results help clarify which protocols are most effective and safest, given the lack of consensus in current practice.

Clinical efficacy and safety of two highly purified human menopausal gonadotropins in women undergoing in vitro fertilization.

Published: March 31, 2025

AI Summary

Gynogen HP and Menopur, two purified human menopausal gonadotropin products, produced similar numbers of eggs and comparable pregnancy rates in IVF. Gynogen HP was non-inferior to Menopur with a similar safety profile, supporting its use in ovarian stimulation.

HMG Box-containing Protein 1 (HBP1) Protects Against Pancreatic Injury in Acute Pancreatitis but Promotes Neoplastic Progression.

Published: May 19, 2025

AI Summary

HBP1 protects the pancreas during acute pancreatitis but appears to promote progression to pancreatic cancer. The dual role highlights the complexity of transcription factors in inflammation and cancer and may inform future therapeutic strategies.

Protective Effect of HMG-CoA Reductase Inhibitor Rosuvastatin on Doxorubicin-Induced Cognitive Impairment, Oxidative Stress and Neuroinflammation: Possible Role of CREB, ERK1/2, and BDNF.

Published: May 12, 2025

AI Summary

Rosuvastatin reduced chemotherapy-induced cognitive problems in rats by lowering oxidative stress and inflammation and restoring brain growth factors. The results suggest statins might help protect cognition during cancer treatment, though clinical trials are needed.

Lipid liquid-crystalline nanoparticles as a suitable platform for accommodating sensitive membrane proteins: monitoring the activity of HMG-CoA reductase.

Published: May 6, 2025

AI Summary

HMG-CoA reductase was enclosed in lipid nanoparticles, keeping the enzyme stable and active so its function could be monitored and inhibited by fluvastatin. The approach could support discovery of new cholesterol-lowering drugs and other membrane protein modulators.

Does HCG and LH supplementation during ovarian stimulation improve clinical outcome? An evaluation of 30 years of clinical research.

Published: June 22, 2025

AI Summary

A review of 30 years of trials found no clear proof that adding HCG or LH to FSH improves pregnancy rates. HMG sometimes yielded fewer eggs but similar or slightly higher pregnancy rates, possibly because pure FSH can cause earlier progesterone rises that harm outcomes.

A novel approach to assessing the bioavailability of biopeptide inhibitor of HMG CoA reductase from germinated and ungerminated Kara Kratok (Phaseolus lunatus L.).

Published: April 22, 2025

AI Summary

The bioavailability of cholesterol-lowering peptides from lima beans was assessed in germinated and ungerminated forms. The work addresses a key hurdle in developing food-derived peptides as health-promoting ingredients: surviving digestion and reaching the bloodstream.

Enhancing mycophenolic acid production in Penicillium brevicompactum through Kozak-optimized 2A peptide multi-gene expression system.

Published: May 10, 2025

AI Summary

Optimizing gene expression in a fungus with a Kozak sequence increased production of mycophenolic acid by nearly 50% and improved cell growth. The approach offers a useful strategy for engineering fungi to make drugs and other compounds more efficiently.

RAS70 peptide targets multiforme glioblastoma by binding to the plasma membrane heat shock protein HSP70.

Published: March 23, 2025

AI Summary

A peptide that targets heat shock protein on glioblastoma cells crossed the blood-brain barrier and accumulated in tumors in mice and human tissue. The peptide could support tumor imaging during surgery and may serve as a carrier for drug delivery to brain tumors.

Gonadotropins for ovulation induction in women with polycystic ovary syndrome.

Published: April 6, 2025

AI Summary

Gonadotropin protocols for inducing ovulation in PCOS were reviewed, as FSH is used when clomiphene or letrozole fail. The work summarizes how different protocols and gonadotropin types are used in this population.

Human menopausal gonadotropin (HMG) combined different doses of letrozole for treating anovulatory infertility in patients with polycystic ovary syndrome: a randomized controlled trial.

Published: June 6, 2025

AI Summary

Letrozole at 2.5 mg versus 5 mg combined with HMG was compared for ovulation induction in infertile PCOS patients. The trial aimed to optimize protocols and compare ovulation rates and side effects between the two doses.

SOX4 accelerates intervertebral disc degeneration via EZH2/NRF2 pathway in response to mitochondrial ROS-dependent NLRP3 inflammasome activation in nucleus pulposus cells.

Published: April 2, 2025

AI Summary

SOX4 speeds up disc degeneration by activating the NLRP3 inflammasome in response to mitochondrial stress, via the EZH2–NRF2 pathway. The findings clarify how disc cells respond to stress and may point to new targets for treating back pain and disc disease.

Frequently Asked Questions

What is HMG?

A fertility medication made from hormones extracted from postmenopausal women's urine. It contains both the hormones that stimulate egg development in women and sperm production in men. Used for fertility treatment in both sexes. Some bodybuilders also use it after steroid cycles to help their natural hormone production bounce back.

What is HMG used for?

A fertility medication made from hormones extracted from postmenopausal women's urine. It contains both the hormones that stimulate egg development in women and sperm production in men. Used for fertility treatment in both sexes. Some bodybuilders also use it after steroid cycles to help their natural hormone production bounce back.

What is the dosage for HMG?

Fertility (women): 75-150 IU intramuscular once daily, physician-directed with ultrasound monitoring. PCT/bodybuilding: 75-150 IU intramuscular every other day for 1-2 weeks, often alongside HCG.

What are the side effects of HMG?

Common: pain and bruising at the injection site, headache, bloating, tender breasts. Serious: in women, can cause dangerous overstimulation of the ovaries (potentially life-threatening), and increases the chance of twins or higher-order multiples; in men, can cause breast tissue growth. Rare: blood clots, twisted ovary, severe allergic reaction. Requires close monitoring with blood tests and ultrasounds during fertility treatment.

How does HMG work?

Human Menopausal Gonadotropin is a purified urinary extract containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity, sourced from the urine of postmenopausal women. After menopause, the loss of ovarian negative feedback (estradiol and inhibin) results in dramatically elevated pituitary gonadotropin secretion — FSH and LH levels rise 10-20 fold, providing a natural source of these hormones for pharmaceutical extraction. The FSH component binds to FSH receptors (FSHR) on Sertoli cells in males and granulosa cells in females. FSHR is a Gs-coupled GPCR that activates cAMP/PKA signaling, driving the expression of genes essential for gametogenesis. In males, FSH-stimulated Sertoli cells produce androgen-binding protein (which concentrates testosterone locally), inhibin B (which provides negative feedback to the pituitary), and multiple growth factors that support spermatogonial proliferation and differentiation through the stages of spermatogenesis. In females, FSH drives follicular development — stimulating granulosa cell proliferation, estradiol synthesis via aromatase induction, and the growth of ovarian follicles from the pre-antral to the pre-ovulatory stage. The LH component acts on Leydig cells in males (stimulating testosterone production via the LHCGR/cAMP/StAR steroidogenic pathway) and on theca cells in females (stimulating androgen precursor production that granulosa cells convert to estradiol). In females undergoing fertility treatment, the LH component is also critical for final oocyte maturation and ovulation triggering. The combination of both FSH and LH activity in HMG provides more complete gonadal stimulation than either gonadotropin alone — FSH drives the cellular proliferation and maturation processes while LH provides the steroidogenic and final maturation signals. This dual activity is why HMG is sometimes preferred over purified FSH preparations in certain fertility protocols, particularly in hypogonadotropic patients who lack endogenous LH.

How is HMG administered?

HMG is administered via intramuscular or subcutaneous injection.

What is the half-life of HMG?

The half-life of HMG is FSH component: 30 hours | LH component: 24 hours.

Is HMG legal?

FDA approved for fertility (Menopur, Repronex). Prescription required. Available through fertility clinics and pharmacies.

Related Peptides

ACE-031

An experimental drug that acts as a 'decoy' to intercept myostatin and other muscle-limiting signals before they reach your muscles. It produced rapid muscle gains in clinical trials without any exercise. However, development was halted because it also accidentally blocked signals needed to maintain healthy blood vessels, causing nosebleeds and visible broken blood vessels. A powerful proof-of-concept that myostatin blocking works, but too dangerous in its current form.

Bodybuilding

AICAR

A natural compound that activates your cells' energy sensor — the same pathway that turns on during exercise. Mimics the metabolic effects of endurance exercise at the cellular level, helping with fat burning, glucose uptake, and building more mitochondria. Banned by WADA as a metabolic modulator after detection in professional cycling.

MetabolicBodybuilding

Alprostadil

A medication that treats erectile dysfunction by relaxing the blood vessels in the penis, allowing blood to flow in and create an erection. Unlike pills that require arousal to work, this works directly at the injection or application site — you don't need to be in the mood. Available as an injection into the penis or as a small pellet inserted into the urethra.

Sexual Health

BPC-157

A healing compound made from a protein found in stomach fluid. It's the most studied peptide for tissue repair, with research showing it helps heal tendons, ligaments, muscles, the gut, and other organs. It's stable enough to survive stomach acid, so you can take it either by injection under the skin or by mouth.

HealingBodybuilding